What is the maximum adult dose of Lasix (furosemide) orally and intravenously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dosage of Lasix (Furosemide)

The maximum adult dose of oral furosemide is 600 mg per day, and for intravenous administration the maximum single bolus is 160–200 mg with a maximum daily dose of 600 mg (up to 620 mg in continuous infusion protocols). 1, 2

Oral Furosemide Maximum Dosing

  • Standard maximum daily dose: 600 mg/day in patients with clinically severe edematous states 2
  • Initial dosing typically starts at 20–80 mg as a single dose, with increases of 20–40 mg given no sooner than 6–8 hours after the previous dose until desired diuretic effect is achieved 2
  • When doses exceeding 80 mg/day are given for prolonged periods, careful clinical observation and laboratory monitoring are particularly advisable 2
  • Higher doses (up to 4,000 mg/day) have been used safely in refractory cases under strict monitoring, though this is not routine practice 3, 4

Intravenous Furosemide Maximum Dosing

Single Bolus Limits

  • Maximum single IV bolus: 160–200 mg 5, 6
  • Initial dose is typically 20–40 mg given slowly over 1–2 minutes 1
  • For patients already on chronic oral diuretics, the initial IV dose should be at least twice the total daily oral dose (e.g., 40 mg PO daily → ≥80 mg IV) 6, 1

Short-Term Dose Limits

  • First 6 hours: total dose should not exceed 100 mg 6
  • First 24 hours: total dose should not exceed 240 mg 6
  • These limits are designed to reduce toxicity risk while allowing effective decongestion 6

Maximum Daily Dose

  • Standard maximum: 600 mg per day 5, 6, 2
  • Continuous infusion protocols: up to 620 mg per day 6
  • In refractory cases with severe heart failure and reduced renal function, doses up to 1,000–4,000 mg/day have been used successfully without major side effects, though this requires intensive monitoring 3, 7, 4

Continuous Infusion Dosing

  • Loading dose: 40 mg IV bolus 5, 6
  • Infusion rate: 5–20 mg/hour initially, maximum 40 mg/hour (not exceeding 4 mg/min) 5, 6
  • Titrate by doubling the infusion rate every 1–2 hours until urine output ≥0.5 mL/kg/hour is achieved 6
  • Continuous infusion is at least as safe and more effective than repeated large-dose boluses in severe heart failure 8

Special Populations and Safety Considerations

Pediatric Dosing

  • Usual initial dose: 2 mg/kg body weight as a single dose 2
  • May be increased by 1–2 mg/kg no sooner than 6–8 hours after previous dose 2
  • Maximum: 6 mg/kg body weight (doses greater than this are not recommended) 2
  • For prolonged use: do not exceed 6 mg/kg/day for more than 1 week to prevent ototoxicity 9

Geriatric Patients

  • Dose selection should be cautious, usually starting at the low end of the dosing range 1, 2
  • The recommended dose for patients >59 years receiving parenteral therapy should be reduced to 10 mg/kg/day (750 mg maximum) when using streptomycin concurrently 10

Renal Impairment

  • Higher doses are often required in patients with reduced renal function because drug delivery to tubular sites of action is impaired 5
  • In severe renal dysfunction (creatinine >250 µmol/L or >2.8 mg/dL), higher doses may be necessary but require careful monitoring 6, 4

Critical Safety Parameters

Ototoxicity Prevention

  • Infuse over 5–30 minutes to reduce hearing loss risk 9, 6
  • Do not exceed 6 mg/kg/day for more than 1 week 9
  • Avoid concurrent use with loop-inhibiting diuretics (ethacrynic acid) which increases ototoxicity risk 10
  • Short-term, reversible hearing loss has been reported with high-dose bolus injection but not with continuous infusion 8

Monitoring Requirements

  • Daily monitoring of serum electrolytes (K⁺, Na⁺, Mg²⁺), renal function (creatinine, BUN), body weight, and fluid balance is mandatory during high-dose therapy 6
  • Hourly urine output measurement (preferably via catheter) to assess diuretic response 6
  • Blood pressure monitoring every 1–4 hours 6

Electrolyte Management

  • Hypokalemia is the most common adverse effect and requires aggressive replacement 5, 6
  • Add spironolactone 25–50 mg PO daily or amiloride to prevent recurrent potassium depletion and provide synergistic natriuresis 6
  • Hypomagnesemia should be corrected as it impairs potassium repletion 6

When Maximum Doses Fail (Diuretic Resistance)

  • Add a thiazide-type diuretic (metolazone 2.5–5 mg PO or chlorothiazide 500–1,000 mg IV) for sequential nephron blockade 5, 6
  • Add an aldosterone antagonist (spironolactone or eplerenone 25–50 mg PO daily) 6
  • Low-dose combination therapy is more effective and produces fewer adverse effects than high-dose loop diuretic monotherapy 6
  • Consider ultrafiltration in refractory cases with stable renal function 6

Contraindications to Dose Escalation

  • Anuria (furosemide must be stopped) 9
  • Severe hyponatremia (Na⁺ <120–125 mmol/L) requires temporary discontinuation 11
  • Severe hypovolemia or hypotension (systolic BP <90 mmHg predicts poor response; consider inotropic support while continuing diuretics) 6
  • Acute kidney injury with oliguria and creatinine >3 mg/dL warrants withholding diuretics pending nephrology review 11

References

Research

High dose furosemide in refractory cardiac failure.

European heart journal, 1985

Guideline

Intravenous Furosemide Infusion Protocol for Fluid Overload with Bilateral Crackles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Furosemide Management in Acute Fluid Overload and Cirrhotic Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.